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In the early steps of visual signal transduction, light-activated rhodopsin (R*) catalyzes GDP/GTP exchange in the heterotrimeric G
protein (Gabc) transducin. We recently reported that the catalytic interaction involves two sequential steps. An initial docking between
R* and Gbc leads to conformational changes which make the C-terminus of Ga (CTa) available for binding to R*. Binding of CTa by
R* then triggers GDP/GTP exchange in the Ga subunit. To further study this two-step mechanism, we investigated diﬀerent single ami-
no acid substitutions within CTa and discuss the eﬀects of high aﬃnity mutations on nucleotide exchange catalysis.
 2006 Elsevier Ltd. All rights reserved.
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In numerous signalling pathways, heterotrimeric guan-
ine nucleotide binding proteins (G proteins, Gabc) trans-
duce extracellular signals sensed by transmembrane G
protein-coupled receptors (GPCRs) to intracellular eﬀec-
tor proteins (Cabrera-Vera et al., 2003). A prototypical
GPCR2 is rhodopsin, the visual pigment of rod photore-
ceptor cells, which is responsible for vision under dim0042-6989/$ - see front matter  2006 Elsevier Ltd. All rights reserved.
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* Corresponding authors. Present address: Duke University Eye Center, AE
Herrmann).
E-mail addresses: rolf.herrmann@duke.edu (R. Herrmann), oliver.ernst@c
1 Rolf Herrmann and Martin Heck contributed equally to this work.
2 Abbreviations used: G protein, guanine nucleotide-binding regulatory protei
and c-subunit of the G protein; Gat, a-subunit of Gt; CTa, C-terminal tai
metarhodopsin I; MII, metarhodopsin II; Mes, 2-morpholinoethanesulfoni
thiopyridone; DTT, dithiothreitol; R*, signalling active state of rhodopsin; RO
NOE, nuclear Overhauser eﬀect; NOESY, nuclear Overhauser enhancem
spectroscopy; TOCSY, total correlation spectroscopy; 1D, one dimensional;
amino acids.light conditions. In its dark adapted state, the chromo-
phore 11-cis retinal is covalently bound as an inverse ago-
nist and keeps the receptor inactive. Upon photon
absorption, 11-cis! all-trans retinal isomerization induc-
es conformational changes in the protein moiety and
starts formation of a series of photointermediates (Ernst
& Bartl, 2002). In milliseconds, an equilibrium between
the two photoproducts metarhodopsin I (MI) and meta-
rhodopsin II (MII) is reached. The G protein binds toRI, Erwin Road, Durham, NC 27710, USA. Fax: +1 919 684 3826 (R.
harite.de (O.P. Ernst).
n; GPCR, G protein-coupled receptor; Gt, transducin; Ga, Gb, Gc, a-, b-,
l of Ga; CTc-far, farnesylated C-terminal tail of Gc; far, farnesyl; MI,
c acid; 4-PDS, 4,4 0-dithiodipyridine (4,40-dipyridyl disulﬁde); 4-TP, 4-
S, rod outer segments; NMR, nuclear magnetic resonance spectroscopy;
ent spectroscopy; ROESY, rotating frame Overhauser enhancement
2D, two dimensional; single- and three-letter abbreviations are used for
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Fig. 1. Amino acid sequences of C-terminal Gat-derived peptides and
interaction with metarhodopsin II (MII). (A) The a, b and c subunits
of the G protein transducin are shown in green, blue and magenta
(Protein Data Bank Accession No. 1GOT). Key binding sites for the
active receptor are the C-terminus of Ga (CTa) and the farnesylated
C-terminus of Gc (CTc), which were modelled according to NMR
data (Kisselev & Downs, 2003; Kisselev et al., 1998) (both shown in
orange, myristoylation at the Ga N-terminus is shown in grey).
Amino acid sequences correspond to the C-terminal tail of Gat
(CTat: residues 340–350), Gai1 (CTai: residues 344–354) or are
modiﬁed from the CTat sequence. The CTa sequences were studied
either as synthetic peptides, C-terminal MBP fusion proteins or as C-
terminal sequence as part of Ga subunits. (B) MII is formed due to
ﬂash activation and stabilized in a concentration dependent manner
by the peptide CTaL (pH 8.0, 4 C, 10 lM rhodopsin in ROS
membranes, 11.5% of rhodopsin is ﬂash activated, ﬂash symbol
indicates time of activation, peptide concentration as indicated). The
amount of peptide-induced MII (‘extra-MII’) is the diﬀerence between
the maximal DAbs values obtained with and without peptide. (C) The
relative amount of peptide induced ‘extra-MII’ is plotted against the
peptide concentration and ﬁtted hyperbolically considering substrate
depletion (for ﬁt equation see Appendix A). Curves are normalized to
the saturation level. Error bars are omitted for clarity. Data points
are averages of three independent determinations. Derived dissociation
constants are given in Table 1. (For interpretation of the references in
color in this ﬁgure legend, the reader is referred to the web version of
this article.)
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tion (R*) capable of catalyzing GDP/GTP exchange in
the retinal G protein transducin (Gt) (Okada, Ernst, Pal-
czewski, & Hofmann, 2001). Earlier studies have shown
that two key binding sites on Gt, namely the C-terminal
tail of Ga (CTat; Gat(340–350); Fig. 1A) and the farnesy-
lated C-terminal tail of Gc (CTc-far; Gc1(60–71)far),
interact with R* and are involved in nucleotide exchange
catalysis (Garcia, Onrust, Bell, Sakmar, & Bourne, 1995;
Hamm et al., 1988; Herrmann et al., 2004; Kisselev,
Ermolaeva, & Gautam, 1994; Kisselev, Meyer, Heck,
Ernst, & Hofmann, 1999; Morizumi, Imai, & Shichida,
2003). Like Gt, peptides corresponding to CTat and
CTc-far are capable of binding to MII (Bartl, Ritter, &
Hofmann, 2000; Kisselev et al., 1999). Transferred
NOESY NMR experiments showed that these peptides
are disordered in solution. Upon binding to R*, CTat-de-
rived peptides adopt a helical conformation with a helix-
terminating C-capping motif (as modelled in Fig. 1; Brab-
azon, Abdulaev, Marino, & Ridge, 2003; Kisselev et al.,
1998; Koenig et al., 2002). Furthermore, CTat-derived
peptides containing multiple substitutions are known to
possess increased aﬃnity for R*. Analysis of the peptide
sequences suggests that removal of the positive charge
at the N-terminus of the peptide and at Lys341 (Gat num-
bering) increases the aﬃnity for R* (Aris et al., 2001;
Herrmann et al., 2004; Martin, Rens-Domiano, Schatz,
& Hamm, 1996).
Recently, we proposed a model in which the G protein
interacts with R* according to a sequential two step mech-
anism (Herrmann et al., 2004). CTa is not available for
interaction with R* in Gabc before an initial docking step
between R* and the farnesylated Gbc dimer has occurred.
A mutant G protein containing the high aﬃnity K341L
substitution (Gat numbering) in CTa showed an increased
rate of GDP release and accelerated GTP uptake, support-
ing a direct involvement of CTa in the nucleotide exchange
reaction.
In the present work, we characterize the eﬀect of diﬀer-
ent amino acid substitutions at CTa’s key position Lys341.
We studied the R* aﬃnity of mutant G proteins, synthetic
CTa derived peptides and fusion proteins with CTa pep-
tides. Analysis of binding data, probing the reactivity of
a Cys residue in CTa peptides, and NMR studies allowed
insights into a complex interplay between rhodopsin and
the C-terminal region of transducin.
2. Materials and methods
2.1. Peptide synthesis
Peptide synthesis and puriﬁcation were as described previously
(Ernst et al., 2000b). Puriﬁed and lyophilized peptides were dissolved
in water and the pH was adjusted with 1 M NaOH up to pH 5–6.
Sequences of peptides were derived from the C-terminus of bovine
Gat. Amino acid sequences of the peptides were as in Fig. 1A. Unless
otherwise mentioned, the carboxyl and amino termini of the peptides
were unmodiﬁed.
Table 1
Dissociation constants of the peptideÆMII complex
Peptide KD (lM)
CTat 83.1 ± 12.2
Ac-CTat 24.2 ± 1.6
CTai 94.7 ± 7.3
CTaL 0.39 ± 0.02
CTaI 0.47 ± 0.02
CTaV 1.70 ± 0.06
CTaF 2.17 ± 0.09
CTaE 16.8 ± 1.6
CTaS 42.6 ± 3.3
CTaA 28.0 ± 2.0
KD values were derived from ‘extra-MII’ measurements in Fig. 1 and are
10 times smaller than the values of half-maximal ‘extra-MII’ formation
(EC50 values) due to the MI/MII pre-equilibrium. Ac denotes acetylation
at the N-terminus. Values are averages of three independent determina-
tions. Errors are given as the standard error of the means (SEM).
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Bovine eyes were obtained from a local slaughter house. Rod outer
segments (ROS) and rhodopsin membranes were prepared as described
previously (Herrmann et al., 2004). Gabc was puriﬁed and separated into
Ga and Gbc subunits by chromatography on a cibacron blue column
(HiTrap Blue, GE Healthcare Life Sciences) as described (Heck & Hof-
mann, 2001).
2.3. Cloning, expression, and puriﬁcation of Ga subunits
Nonmyristoylated Ga subunits were expressed and puriﬁed from E.
coli as described (Herrmann et al., 2004). Experiments were performed
with Gai1 which in combination with the Gb1c1 isoform couples to rho-
dopsin as well as transducin (Gat/Gb1c1) (Herrmann et al., 2004). The
plasmid pGiL harbouring the rat Gai1 coding sequence with an internal
His6-tag was used for construction of Gai1 mutants (Herrmann et al.,
2004). pGiL was partially digested with AatII and HindIII and ligated
with synthetic DNA duplexes encoding the last 14 C-terminal amino acids
of native Gat or Gat containing the substitutions K341L or K341V,
respectively.
2.4. Cloning, expression and puriﬁcation of MBP fusion proteins
Cloning, expression and puriﬁcation of the maltose binding protein
(MBP) fusion proteins containing at the MBP C-terminus a Gly-Gly link-
er and 11 amino acids derived from the Gat C-terminus was as described
previously (Herrmann et al., 2004).
2.5. ‘Extra-MII’ assay
The amount of ‘extra-MII’ (absorption maximum at k = 380 nm) was
recorded by time-resolved UV/visible spectroscopy as described previously
(Ernst, Bieri, Vogel, & Hofmann, 2000a). Recorded traces represent the
time dependency of absorption diﬀerences (A380–A417; the isosbestic point
between MI and MII is at 417 nm) from samples containing 10 lM rho-
dopsin in ROS membranes. Measurements were performed at pH 8.0
and 4 C. Cuvette path length was 2 mm. 11.5% of rhodopsin was ﬂash-ac-
tivated by 500 ± 20 nm light.
2.6. Fluorescence spectroscopy
G protein activation was monitored by relative changes in ﬂuorescence
emission at k = 340 nm (excitation at k = 300 nm). Samples containing
rhodopsin (50 nM) in ROS membranes were illuminated with green light
(k > 495 nm, 10 s) and the reaction was started by addition of GTPcS
(5 lM ﬁnal concentration) at 20 C and constant stirring (Ernst et al.,
2000a).
2.7. Near-infrared kinetic light scattering
Changes in light-scattering intensities were measured as described pre-
viously (Herrmann et al., 2004). Measurements were performed in 10 mm-
path cuvettes at pH 7.5, 23 ± 1 C and with 3 lM rhodopsin in ROS mem-
branes. 32% of rhodopsin were activated using ﬂashes of green light
(k = 500 ± 20 nm).
2.8. Nuclear magnetic resonance spectroscopy
1D and 2D TOCSY (mixing time 110 ms), ROESY (mixing time
200 ms) and NOESY (mixing time 200 ms) 1H NMR spectra were record-
ed at various temperatures on a Bruker AVANCE DMX 600 NMR spec-
trometer locked to the deuterium resonance of the solvent. Samples of
CTat and CTaL peptides (Fig. 1A) were dissolved in various solvents
(50% triﬂuoroethanol-d2: 50% H2O at pH ca. 3; 90% H2O: 10% D2O,
pH ca. 3; 90% aqueous phosphate buﬀer: 10% D2O, pH 6.5; 90% aqueousphosphate buﬀer: 10% D2O, pH 7.5) and NMR spectra were recorded of
both under identical conditions. Standard analysis of these data aﬀorded
the unambiguous sequential signal assignments in all cases. The cross
peaks in the ROESY spectra taken at 285 K of the 90% aqueous phos-
phate buﬀer: 10% D2O solution at pH 7.5 containing 14 mM DTT of both
peptides (7 mM) were integrated and calibrated against the peak of the
asparagine side-chain amide group.
2.9. Determination of the reaction rate between peptides and 4-PDS
The investigation of the chemical reactivity of sulfhydryl groups of
CTa peptides was essentially performed as described (Cai, Langen, Hub-
bell, & Khorana, 1997; Klein-Seetharaman et al., 1999). 4,4 0-Dithiodipyri-
dine (4-PDS) in MES buﬀer (20 mM Mes, 130 mM NaCl, and 1 mM
MgCl2, pH 6.0) was added to peptide in Mes buﬀer such that the ﬁnal con-
centrations were 2.5 mM 4-PDS and 45 lM peptide. The reaction at 20 C
was followed by monitoring the time course of absorption change at
k = 323 nm due to the formation of 4-thiopyridone (4-TP), using a Cary
50 UV/visible spectrophotometer (Varian). The cuvette path length was
10 mm.
3. Results
3.1. CTat-derived peptides with substitution of Lys341 by
hydrophobic residues have increased aﬃnity for R*
We explored how single amino acid substitutions at
position 341 (Gat numbering) can increase the aﬃnity of
CTa for R*. By employing the ‘extra-MII’ assay (Emeis,
Ku¨hn, Reichert, & Hofmann, 1982), we determined aﬃni-
ties of CTat-derived synthetic peptides (Fig. 1A, Table 1).
This assay is based on the depletion of the MI photoprod-
uct and makes use of the fact that peptides, which stabilize
the active MII conformation (kmax = 380 nm), do this at
the expense of the tautomeric MI photoproduct
(kmax = 480 nm). This increase of absorption caused by
MII formation can be measured by UV/visible spectrosco-
py after ﬂash activation of rhodopsin (Fig. 1B).
All investigated CTa peptides stabilized MII in a
concentration dependent manner. This is presented for
CTaL (containing the K341L substitution) in Fig. 1B,
showing eight superimposed time resolved ‘extra-MII’
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Fig. 2. Interaction between the MBP-CTaF fusion protein and R*.
Binding of the fusion protein MBP-CTaF to R* was measured by kinetic
light scattering. Inset, the increase in the relative intensity of scattered light
(DI/I) observed after rhodopsin activation reﬂects the formation of the
R*ÆMBP–CTaF complex (binding signal; 3 lM rhodopsin in ROS
membranes, 32% rhodopsin was activated by a green ﬂash, pH 7.4,
23 C, ﬂash symbol indicates time of rhodopsin activation). Concentra-
tions of the fusion protein were as indicated. Amplitudes of binding
signals are plotted against the MBP–CTaF concentration. Hyperbolically
ﬁtting of the data points yields an EC50 value of 1.6 lM. Shown are data
points from a representative measurement.
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of CTaL peptide (0–100 lM). Amplitudes of absorption
traces corrected for the amplitude of the reference trace
(without peptide) deﬁne the amount of MII stabilized by
added peptide (‘extra-MII’). The amount of ‘extra-MII’
was plotted against the corresponding peptide concentra-
tion of the diﬀerent peptides investigated (Fig. 1C). Hyper-
bolically ﬁtting of the data points yielded an EC50 value of
3.9 lM in the case of CTaL. This corresponds to a dissoci-
ation constant (KD) of 0.39 lM for the MIIÆpeptide com-
plex, taking into account the MI/MII pre-equilibrium
under the experimental conditions of the ‘extra-MII’ assay
(approx. 90% MI and 10% MII, see Parkes & Liebman,
1984).
The same experiment was performed with peptides
CTaI, CTaV, CTaF, CTaE, CTaS, CTaA (amino acid
substitutions K341I, K341V, K341F, K341E, K341S and
K341A, respectively), the native CTat peptide, N-terminal
acetylated CTat peptide (Ac-CTat), and the CTai peptide
(which corresponds to the CTat E342N substitution).
The derived dissociation constants are given in Table 1.
The determined KD values for CTat and CTai peptides
were similar (83.1 vs. 94.7 lM) suggesting that the negative
charge at position 342 has little inﬂuence on the aﬃnity for
R*. Removal of the positive charge at the peptide’s N-ter-
minus by acetylation decreased the KD value by a factor of
3 (KD = 24.2 lM). Removal of the positive charge of
Lys341 by substitution with a hydrophic residue increased
the peptide aﬃnity for R* by two orders of magnitude as
exempliﬁed by CTaL and CTaI (KD = 0.39 and 0.47 lM,
respectively). A slightly smaller or larger hydrophobic side
chain such as Val or Phe (CTaV or CTaF) led to an
increased aﬃnity of about one order of magnitude (KD val-
ues are 1.70 lM for CTaV and 2.17 lM for CTaF, Table
1). The substitutions K341E, K341S and K341A just slight-
ly increased the peptide aﬃnities (KD values are 16.8, 42.6
and 28.0 lM, respectively, Table 1).
Next, we determined the aﬃnities of the more hydro-
phobic CTaL and CTaF by a second approach. The CTaF
peptide was expressed as fusion protein with maltose bind-
ing protein (MBP), yielding ‘‘mass-tagged’’ peptides. Bind-
ing of the MBP-CTaF fusion protein to R* was
investigated by kinetic light scattering (Fig. 2), a real time
monitor for rhodopsin/G protein interaction (Heck, Pul-
vermu¨ller, & Hofmann, 2000; Herrmann et al., 2004). Syn-
thetic peptides without a ‘‘mass-tag’’ are too small to yield
signals in the light scattering assay (Herrmann et al., 2004).
The complex formation between R* and its binding partner
is reﬂected by an increase in the relative intensity of scat-
tered light (DI/I, binding signal) after activation of rhodop-
sin by a green light ﬂash. Similar to the isolated peptide in
the ‘extra-MII’ assay, MBP-CTaF binds to R* in a concen-
tration dependent manner. Analysis of the amplitudes of
the binding traces yielded an EC50 value (concentration
of half maximal saturation) of 1.6 lM (KD of 1.3 lM, see
Appendix A), which is similar to the dissociation constant
obtained by the ‘extra-MII’ assay (2.17 lM, Table 1).The same light scattering experiment was performed with
MBP-CTaL, yielding aKD of 0.2 lM(data not shown). This
is in good agreement with the dissociation constant obtained
by the ‘extra-MII’ assay for the corresponding synthetic
peptide CTaL (0.39 lM, Table 1). A similar conformity
was found for the CTat-derived peptide VLEDLKSCGLF
that showed high aﬃnity for R* (KD = 0.36 lM as deter-
mined by the ‘extra-MII’ assay; data not shown), in agree-
ment with earlier determinations (Aris et al., 2001;
Herrmann et al., 2004; Kisselev et al., 1999).
3.2. The K341L substitution in CTa aﬀects the aﬃnity of the
G protein only marginally
The K341L substitution greatly enhances the aﬃnity of
the CTa peptide for R* (Fig. 1B and C). Therefore, we next
characterized the eﬀect of this substitution on G protein
binding to R*. We expressed mutants of the nonmyristoy-
lated Gai1 subunits harbouring the CTat or CTaL
sequence in Escherichia coli (subunits are termed Ga–CTat
or Ga–CTaL, respectively; Ga–CTai represents Gai1). For
these studies Gai1 was chosen, because it belongs to the
same Ga subfamily as Gt, couples with Gbc to rhodopsin
and can be expressed in high quantities in E. coli (Herr-
mann et al., 2004).
The R*-catalyzed GDP/GTP exchange in these G pro-
teins was measured by ﬂuorescence spectroscopy. After
illumination of the sample and addition of GTPcS, the
uptake of GTPcS is accompanied by an increase of the rel-
ative ﬂuorescence emission caused by the conformational
change in Ga. The data show that all three G proteins
expressed were functional. The G protein containing the
K341L substitution showed a slightly faster GTPcS uptake
kinetics compared to Ga–CTai (Fig. 3). This is in
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Fig. 4. Stabilization of MII by G proteins containing the Ga–CTat, Ga–CTaL
(B) Ga–CTai/Gbc and (C) Ga–CTaL/Gbc. In the absence of Ga/Gbc, no
activation. Measuring conditions were as in Fig. 1B. (D) Evaluation of the
Calculated EC50 values are 2.5 ± 0.55 lM (Ga–CTat/Gbc), 2.8 ± 0.71 lM (Ga
as means ± SE. The error bars display the standard deviation of two measureWe determined the R* aﬃnities of the prepared G pro-
teins by ‘extra-MII’ measurements. Fig. 4 shows seven
superimposed ‘extra-MII’ traces in the presence of various
concentrations of Ga–CTat/Gbc (Fig. 4A, 0–8 lM), Ga–
CTai/Gbc (Fig. 4B, 0–8 lM) and Ga–CTaL/Gbc
(Fig. 4C, 0–7 lM), respectively. Surprisingly, stabilization
of MII was observed for all three Ga/Gbc combinations
in a similar manner. By hyperbolically ﬁtting of the signal
amplitudes we obtained very similar EC50 values for all
three G proteins. The values were 2.5 lM (Ga–CTat/
Gbc), 2.8 lM (Ga–CTaL/Gbc) and 2.0 lM (Ga–CTai/
Gbc), respectively.
These experiments indicate similar R* aﬃnities of the
three G proteins. Next, we used the kinetic light scattering
assay to verify these results under more physiological con-
ditions (23 C and pH 7.4 compared to 4 C and pH 8.0 in
the ‘extra-MII’ assay). In this assay, the light-induced bind-
ing of G proteins from solution to rhodopsin containing
disk membranes is directly monitored as an increase of
the intensity of scattered light (Heck et al., 2000; Herrmann
et al., 2004). In the dark, the three investigated G proteins
were quantitatively located in solution due to the lack of
Ga myristoylation (Herrmann et al., 2004). In this sample,
the maximum level of intensity of scattered light is directly
proportional to the amount of the formed R*ÆG protein
complex after illumination (Heck et al., 2000). Fig. 5 showsG -CT i / G
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Fig. 5. Binding of G proteins containing the Ga–CTat, Ga–CTaL or Ga–CTai subunit to activated rhodopsin. (A) Binding of Ga–CTat in complex with
Gbc to light-activated rhodopsin (R*) was monitored by the increase of the relative intensity of scattered light (DI/I, equimolar concentrations of G
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second equilibrium, CTaa interacts with R* yielding the R*ÆCTab
complex, with CTa in the ﬁnal binding conformation (CTab) (equilibrium
2). (B) Binding of Ga–CTaL to R* in the absence of Gbc investigated by
kinetic light scattering. Protein concentrations were as indicated. Mea-
suring conditions were as in Fig. 2. The arrow indicates time of ﬂash
activation of rhodopsin. The set of binding signals was ﬁtted simulta-
neously on basis of the reaction scheme in (A) and plotted as dotted lines
(red). (For interpretation of the references to color in this ﬁgure legend,
the reader is referred to the web version of this paper.)
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centrations indicated. Aﬃnities are evaluated as performed
for the MBP-CTaF fusion protein (see Fig. 2). The EC50
values for the R*ÆG protein complexes were 0.72 lM
(Ga-CTai/Gbc), 0.69 lM (Ga–CTat/Gbc) and 0.55 lM
(Ga–CTaL/Gbc). Whereas the CTaL substitution
increased the aﬃnity of the CTat peptide by two orders
of magnitude, the same substitution had almost no inﬂu-
ence on the EC50 value of the respective G protein for bind-
ing to the receptor.
3.3. In Ga–CTaL and Ga–CTaV, CTa is accessible for
binding to R*
In the dark, neither Ga–CTat, Ga–CTai, Ga-CTaL nor
Ga-CTaV bound to rhodopsin containing membranes. In
contrast to Ga-CTat and Ga–CTai, the single amino acid
substitution K341L in Ga–CTaL allowed this subunit to
bind very slowly and independently of Gbc to R* in a con-
centration dependent manner (Fig. 6; Herrmann et al.,
2004). No binding of Ga-CTaL was seen when competing
CTaL peptide (50 lM) was added (data not shown). The
same slow Gbc independent binding could be observed
with the Ga–CTaV subunit (carrying the K341V substitu-
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Fig. 7. Reaction rate of CTa peptides with 4-PDS. (A) Reaction scheme
used to ﬁt the measured absorption changes in (B). According to the
scheme the reagent 4,4 0-dithiodipyridine (4-PDS) reacts with the sulfhy-
dryl group of the peptide’s Cys (Cys347 in Gat, Fig. 1A) when the peptide
adopts the inactive CTain conformations. For the active CTaa conforma-
tions, it is assumed that the sulfhydryl group is less accessible for the
reaction. Therefore, 4-PDS reactivity of peptides in the CTaa conforma-
tions is not considered. (B) Time courses of the modiﬁcation of CTa
peptides with 4-PDS are shown for the peptides CTat, CTaL and CTat–S
(CTat-S lacks a sulfhydryl group due to the C347S substitution). The
absorption change at 323 nm (kmax of thiopyridone) is plotted against
time. The reaction was started by the addition of dissolved 4-PDS to the
peptide solution at t = 0 min. Numerical least square ﬁts of the data points
yielded the corresponding rate constants of the reaction scheme in (A)
(summarized in Table 3). The ﬁtted curves are plotted as grey lines.
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CTaL and Ga–CTaV after illumination suggested that in
these mutants the CTa binding site is available for interac-
tion with R* and adopts a conformation that can be recog-
nized by R*. The scheme in Fig. 6A suggests that CTa
exists at least in two diﬀerent conformational states, in an
inactive, non-binding conformation, and in an active R*-
speciﬁc conformation (CTain and CTaa, respectively; equi-
librium 1 in Fig. 6A). The data set (Fig. 6B) was ﬁtted
according to the reaction scheme in Fig. 6A (ﬁt is shown
as dotted red line in Fig. 6B). The rate constants are con-
sistent with the notion that the adoption of the active,
R* binding CTaa conformation is the rate limiting step
(Table 2) which can explain the slow binding of Ga–CTaL
to R*.
3.4. The reactivity of the sulfhydryl group in CTat-derived
peptides is correlated to their aﬃnity for R*
To further test the idea that CTa exists in diﬀerent
conformations (CTain and CTaa), we studied the reactiv-
ity of the sulfhydryl side chain of Cys347 within CTat-
derived peptides (Fig. 7). The NMR structure of a CTat-
derived peptide in the R*-bound conformation shows that
the side chain of residue 347 is shielded by Phe350, Leu349
and Leu344 (PDB code 1LVZ; Koenig et al., 2002). There-
fore, the accessibility of the Cys347 sulfhydryl side chain
may be reduced in the proposed active CTaa conforma-
tion. The reaction scheme in Fig. 7A assumes that only
the inactive CTain conformation reacts with 4-PDS,
whereas the reactivity of the Cys sulfhydryl in the active
CTaa conformation is negligible. We tested this by using
the sulfhydryl speciﬁc reagent 4,4 0-dithiodipyridine (4-
PDS) to determine the reactivity of the Cys347 side chain.
The rate of thiopyridone (4-TP) formation by this reaction
was measured using UV/visible spectroscopy (Fig. 7B)
with the peptides CTat, CTaL and the sulfhydryl lacking
peptide CTat-S containing the C347S substitution. As
expected, no reaction was observed with the control pep-
tide CTat-S. The peptide CTaL reacted slower with 4-
PDS than the native peptide CTat. The data points were
ﬁtted by a numerical least-square ﬁtting procedure on
the basis of the reaction scheme in Fig. 7A (see Appendix
A). The rate constants of the reaction scheme and calculat-
ed equilibrium constants for the equilibrium between
CTain and CTaa are given in Table 3. The equilibrium con-
stant determined for peptides CTat and CTaL is 0.041 and
1.642, respectively. Hence, the equilibrium between CTain
and CTaa is shifted by a factor of 40 to the side of CTaa
due to the K341L substitution.Table 2
Rate constants obtained by ﬁtting the light scattering data in Fig. 6
k1,on (s
1 103) k1,oﬀ (s
1 103) K1 k2,on (lM
1 s
0.1 246.6 0.0004 386.0
K1 = k1,on/k1,oﬀ; KD2= k2,oﬀ/k2,on; KD,app is deﬁned by the product (1/K1) KD23.5. The peptides CTat and CTaL show structural diﬀerences
The reaction scheme presented in Fig. 6A assumes that,
before binding to R*, CTa exists in equilibrium between
two diﬀerent conformational states. Since this equilibrium
is aﬀected by the peptide sequence, we expected that
CTat-derived peptides of diﬀerent aﬃnities show structural
diﬀerences in solution. We performed NMR experiments
under diﬀerent solvent conditions with the aim of measur-
ing structural diﬀerences between the CTat and CTaL pep-
tides. Both peptides produced well resolved 1H NMR
spectra under all solvent conditions used. Peptides showed
a tendency to form dimers through disulﬁde bridge forma-
tion that was particularly prominent at the highest pH (7.5
in aqueous phosphate buﬀer) and could be reversed by the
addition of DTT. At low pH values the samples were stable1 103) k2,oﬀ (s
1 103) KD2 (lM) KD,app (lM)
5.8 0.02 50
; i.e., the ratio (k1,oﬀ. k2,oﬀ)/(k1,on. k2,on).
Table 3
Rate constants obtained by ﬁtting the reaction time courses of CTa peptides with 4-PDS
Peptide k1,on (s
1 103) k1,oﬀ (s
1 103) K1 k2 (s
1 103)
CTat 6.8 166.7 0.041 90.6 ± 4.0
CTaL 24.3 ± 8.3 14.8 ± 4.0 1.642 90.0
Values are averages of at least three independent measurements. Errors are given as the standard error of the means (SEM). No errors are obtained when
parameters were ﬁxed during the ﬁtting session. K1 = k1,on/k1,oﬀ.
Table 4
NOEs observed in 2D ROESY spectra of CTat and CTaL peptides
NOE type Relative intensity
CTat CTaL
N,N CO.NH2 1.000 1.000
N,N (i, i + 1) 10–11 0.099 0.124
N,N (i, i + 1) 9–10 0.027 0.067
N,N (i, i + 1) 8–9 Not observed 0.066
a, dF-11 0.307 0.443
b1, dF-11 0.541 0.808
b2, dF-11 0.582 0.869
a,N(i,i + 2) 9–11 0.014 0.049
a,N(i,i + 2) 8–10 0.005 0.032
a,N(i,i + 2) 7–9 0.013 0.058
2D ROESY spectra (200 ms mixing time) of CTat and CTaL in 90%
aqueous phosphate buﬀer, 10% D2O at pH 7.5 were recorded under
identical conditions at 285 K.
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However, dimer formation could be induced even at pH
3 by bubbling air through the solution.
Initially 50% triﬂuoroethanol-d2: 50% H2O at pH ca. 3
was chosen as solvent assuming that this solvent stabilizes
peptide structures and would therefore allow any major
structural diﬀerences between the peptides to be observed.
Signiﬁcantly no diﬀerences were observed in the cross
peaks in the 2D NOESY and ROESY spectra indicating
both peptides showed the same global behaviour in this sol-
vent system (data not shown). Signiﬁcantly both peptides
showed NH–NH (i, i + 1) ROESY and NOESY responses
for the C-terminal region between K-6 and L-10 (11mer
peptide numbering; corresponding to Lys345 and Leu349
(Gat numbering)). This suggests both peptides have pre-
ferred conformational propensities in this region. The
absence of any medium range NOEs indicated the transient
nature of these structures and implies that both peptides
showed the same behaviour under these hydrophobic
conditions.
In a second set of experiments we used conditions that
corresponded as close as possible to those of the biochem-
ical studies described above, namely 90% aqueous phos-
phate buﬀer: 10% D2O, pH 7.5. Under these conditions
the peptides showed subtle spectral diﬀerences (data not
shown). At room temperature exchange broadening pre-
cludes the observation of most of the amide signals apart
from the C-terminal residues indicating again that only
these residues are in a structured section of the peptides.
Upon lowering the temperature the amide exchange rate
decreases causing the signals to sharpen and increase in
intensity. Comparison of the spectra indicates that CTaL
tends to show sharper signals at all temperatures than
CTat suggesting a more structured state. As expected, there
were few NH–NH (i, i + 1) NOEs in the 2D ROESY spec-
tra recorded at 285 K and these were less intense than those
for the triﬂuoroethanol spectra, indicating the presence of a
structural propensity for the C-terminal region. Important-
ly, there were intensity diﬀerences between the two peptides
for the NH–NH (i, i + 1) NOEs, aH–NH (i, i + 2) NOEs,
and the internal NOEs (aH–dH and bH–dHs) of the termi-
nal Phe residue which indicate the partial ordered nature of
this residue (Koenig et al., 2002). Internal calibration of
these NOEs in the 2D ROESY spectra against the protons
of the Asn side-chain amide group of each peptide allowed
subtle diﬀerences between the peptides to be monitored
(Table 4). Thus in all cases the relative intensity of the rel-
evant NOEs were more intense for CTaL than for CTatimplying a more structured ensemble of likely interconvert-
ing conformations in the former peptide. Our data are
compatible, although somewhat diﬀerent, to those
observed previously by Brabazon and co-workers (Braba-
zon et al., 2003). They observed for the free peptides in
solution a distinct diﬀerential NOESY response between
CTat (IKENLKDCGLF) and a related high aﬃnity pep-
tide (VLEDLKSCGLF), such that only the latter exhibited
the NH–NH (i, i + 1) signals.
4. Discussion
In our preceding work we described a two step sequen-
tial ﬁt mechanism for formation of the nucleotide-free
R*ÆG protein complex. This mechanism includes initial
docking between Gbc and R* which is necessary to make
the C-terminal binding site of Ga, CTa, available for R*
(Herrmann et al., 2004). Further, the main stability of the
nucleotide-free R*ÆG protein complex arises from the inter-
action between CTa and R*. In the present work, we
focused on CTa and examined the eﬀect of mutations with-
in CTa on R*/G protein interaction.
We studied CTa as an isolated binding site (i.e. as syn-
thetic peptide, Fig. 1, or ‘‘MBP-tagged’’ peptide, Fig. 2)
by utilizing two diﬀerent biophysical monitors, UV/visible
spectroscopy (see Fig. 1) and kinetic light scattering
(Fig. 2). Lys341 appeared to be crucial for the CTa aﬃnity.
This is in accordance with other reports that describe the
eﬀect on aﬃnity of multiple-site-substitutions within CTa
(Aris et al., 2001; Kisselev et al., 1998; Martin et al.,
1996). We found that just a single amino acid substitution
CT in CT a R*•CT b
R*
R*
CT t
CT L
A
B
R*
R*
R*
R*
R*
Equil. 1 Equil. 2
GDP
Fig. 8. Possible mechanism to explain the eﬀect of the CTa high aﬃnity
substitutions in the isolated CTa binding site as compared to the G
protein. (A) High aﬃnity substitutions as the single amino acid exchange
K341L in CTaL facilitates the formation of active CTaa conformers ()
from inactive CTain conformers (•) that do not interact with the active
receptor (R*). In complex with R*, the ﬁnal binding conformation CTab
( ) is reached. (B) In the course of the sequential ﬁt interaction between
Gabc and R*, initial contact between R* and Gbc makes CTa available
for R* (Herrmann et al., 2004). The ﬁnal, productive CTa binding
conformation is reached in the second interaction step with concomitant
GDP release. The myristoyl group at the N-terminus of Ga is shown as
grey rectangle; the farnesyl moiety at the Gc C-terminus is shown as black
rectangle. The equilibria between the proposed CTa conformers CTain,
CTaa and CTab are essentially controlled by the R*/G protein interaction,
thereby compensating contributions of CTa high aﬃnity mutations. (For
interpretation of the references in color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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est gain of aﬃnity could be achieved by not only removing
the positive charge of Lys341, but by substitution with
hydrophobic residues. The aﬃnity increase was dependent
on the size of the side-chain, and was two orders of magni-
tude for Leu or Ile and one order of magnitude for Val or
Phe (Table 1). In addition, UV/visible spectroscopy (‘extra-
MII’ assay) showed that removal of the negative charge of
the adjacent Glu342 by substitution with Asn had little
eﬀect on the aﬃnity (Fig. 1C and Table 1).
An explanation for the increased aﬃnity of CTa pep-
tides with hydrophobic substitutions of Lys341 may be
found in the peptide conformation. The structure of CTa
in the R*-bound state was determined by transferred
NOESY NMR studies on synthetic peptides (Kisselev
et al., 1998; Koenig et al., 2002). According to these exper-
iments R*-bound CTa adopts a near-ideal a-helix that is
terminated by a C-capping motif of an aL type with
Gly348 in the centre of the reverse turn (as modelled in
Fig. 1A). This leads to a clustering of hydrophobic side
chains, i.e. Phe350, Leu349 and Leu344, residues which are
highly conserved among G proteins. A CTat-derived pep-
tide with the substitution of Leu349 by the shorter Ala res-
idue (IKENLKDCGAF) fails to stabilize MII even at high
concentrations (Morizumi et al., 2003). Gly348 appears to
be invariant for CTa binding to R* (Garcia et al., 1995).
Phe350 within this hydrophobic cluster is in proximity to
the positively charged Lys341 side-chain, suggesting that
substitution of Lys341 by a hydrophobic residue may have
an eﬀect on the propensity of C-capping formation. Our
NMR experiments show that, in the absence of R*, both
peptides displayed no overall helical or other stable long-
range structures even under hydrophobic conditions which
are known to stabilize secondary structures in peptides.
However, the C-terminal region of the CTa peptides
showed an increased tendency for the formation of partial-
ly structured C-capping-like conformations. This is consis-
tent with the reaction scheme presented in Fig. 6A and
Fig. 8. In this scheme, the peptides exist in two main con-
formational states, an ensemble of disordered, inactive con-
formations CTain, and a partially structured, but still
ﬂuctuating ensemble of conformations, i.e. conformers,
with an increased propensity for the C-terminal C-cap-
ping-motif. This active CTaa ensemble enables interaction
with R*, eventually leading to the R*ÆCTab complex (see
Fig. 8). On basis of the previous NOESY NMR data
(Brabazon et al., 2003; Kisselev et al., 1998; Koenig et al.,
2002) we assume that in the R*-bound state CTab, forma-
tion of the ﬁnal a-helix preceding the terminating C-capping
motif is induced. Importantly, our NMR measurements
indicate that the CTaL peptide is more structured than
CTat in aqueous buﬀer at physiological pH (Table 4). The
high-aﬃnity peptide CTaL exhibits a higher propensity
for C-capping-like conformations in the C-terminal peptide
region. This allows the interpretation that for CTaL, an
increased fraction of active CTaa conformers exists com-
pared to the native CTat peptide (see equilibrium 1 inFig. 8A). Furthermore, it is likely that the more hydropho-
bic Leu residue increases the aﬃnity because it ﬁts better
into its binding pocket of R* (equilibrium 2 in Fig. 8A).
Therefore, in terms of the model in Fig. 8, the observed dis-
sociation constant of the R*Æ peptide complex would be
reduced due to the shift of the coupled equilibria.
Our assumption of CTain and CTaa conformers is sup-
ported by the diﬀerent reactivity of Cys347 within the C-
capping region of CTat and CTaL peptides (Fig. 7). The
fact that the known structures of CTa peptides in the
R*-bound conformation show two diﬀerent orientations
of the Cys347 side-chain, namely either solvent exposed
(PDB: 1AQG) or partially shielded from the solvent
(PDB: 1LVZ), argues also for a variety of C-capping-like
structures in the active CTaa conformers. Therefore, the
sulfhydryl group of Cys347 might be less accessible in the
ensemble of CTaa conformers compared to inactive, ﬂuctu-
ating CTain. With the experiments presented in Fig. 7 we
tested the fraction of native CTat and high aﬃnity CTaL
peptide in the CTain conformational state. Accordingly,
we indeed found a lower Cys reactivity for the high aﬃnity
CTaL peptide (Table 3) which is consistent with an
increased fraction of C-capping-like CTaa conformers with
negligible Cys reactivity.
A further support for this model is provided by light
scattering experiments in which the fraction of active CTaa
conformers is directly probed by complex formation with
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myristoylated Ga-subunits (Ga–CTaL and Ga–CTaV)
enabled binding of Ga to R* in the absence of Gbc. In con-
trast, binding of Ga containing native Lys341 could only
occur in complex with Gbc. Again, the kinetic analysis of
the binding data in Fig. 6 is consistent with the equilibrium
between inactive and active CTa conformers.
In contrast to the CTaL peptide, the fraction of Ga-
CTaL present in the CTaa conformation is low, which
results in the low observed aﬃnity of the isolated Ga–CTaL
subunit (KD, app = 50 lM, Table 3). Therefore, it is likely
that steric and/or conformational constraints exerted with-
in the Ga subunit strongly aﬀect the promotion of active
CTaa conformers. In terms of this interpretation, the intrin-
sic tendency of the native C-terminus to form active CTaa
would not be suﬃcient to overcome these constraints. Inter-
estingly, the kinetic analysis yields a low dissociation con-
stant for the second equilibrium step (equilibrium 2 in
Fig. 6A), reﬂecting the high aﬃnity of the CTaL C-terminus
towards its R* binding site (Kd2 = 0.02 lM). The very slow
binding of this mutated Ga-subunit can be explained by a
rate limiting conformational transition towards active Ga
conformers with subsequent binding to R*. It is interesting
to note that the proposed equilibrium of inactive and active
CTa conformations is in agreement with a study using cyc-
lic CTa peptides that mimic an active, C-capping-like CTaa
conformation. It was found that preorganization of an
active conformation by cyclization led to an increased aﬃn-
ity for MII (Arimoto, Kisselev, Makara, &Marshall, 2001).
It was previously predicted that C-terminal high aﬃnity
mutations within CTa would lead to a higher receptor aﬃn-
ity and a lower activation rate of theGprotein (Martin et al.,
1996). Thus, we examined the eﬀect of the C-terminal high
aﬃnity K341L mutation (CTaL) within the Gabc heterotri-
mer by applying the same biophysical techniques as for the
peptide studies (see Figs. 4 and 5). Surprisingly, in strong
contrast to the behaviour of the peptide and MBP fusion
protein, the K341L substitution did not signiﬁcantly aﬀect
the aﬃnity of mutated Gabc for R*. The three investigated
G proteins (Ga–CTat, Ga–CTai and Ga-CTaL in complex
with Gbc) showed almost identical aﬃnities for R*, as dem-
onstrated by binding to R* in the light scattering assay (see
Fig. 5) and stabilization of MII (‘extra-MII’ assay, see
Fig. 4). It cannot be completely excluded that the lack of
the myristoyl group renders heterotrimeric G proteins con-
taining the wild type or K341L mutant CTa to behave simi-
lar. However, our previous work indicated that CTa
interacts with rhodopsin in a second binding step after initial
docking of the hydrophobic farnesyl and/or myristoyl moie-
ty to rhodopsin (Herrmann et al., 2004, Herrmann, Heck,
Henklein, & Ernst, 2006). Interaction of heterotrimeric Gt
with R* requires the presence of only one hydrophobicmod-
iﬁcation, i.e. farnesylation and myristoylation can replace
each other in the docking process (Herrmann et al., 2004,
2006). Thus the lack of the myristoyl moiety is unlikely to
account for the similarity ofwild type and theK341Lmutant
in binding to R*.The proposal of inactive and active CTa conformers in
context with our previously published sequential ﬁt model
(Herrmann et al., 2004) may give a further hint for the
interpretation of the puzzling discrepancy between peptide
and G protein aﬃnities. The last seven amino acids of the
Ga carboxyl terminus are not resolved in the available
crystal structures of G protein heterotrimers. Furthermore,
Lys341 is oriented towards the solvent and not involved in
intramolecular bonding (Lambright et al., 1996; Wall
et al., 1995). This suggests that the outermost part of the
Ga C-terminal region adopts disordered, ﬂuctuating CTain
conformations in the non-R*-bound G protein. According-
ly, the G protein’s CTa is not available for R* before the
initial binding step via Gbc has occurred and the N-termi-
nal part of CTa is unleashed (Herrmann et al., 2004). We
suggest that this initial docking step serves to position
CTa into the proximity of its binding site on R*. This
diminishes the degrees of freedom of CTain and facilitates
the adoption of an active CTaa conformation (equilibrium
1 in Fig. 8B). In the G protein, CTaL’s increased tendency
to form active CTaa is not crucial, since during the R*ÆG
protein interaction active CTaa conformers are favored
compared to the free peptide. Once formed in the dynamic
R*ÆG protein complex, the C-capping like structures of
unleashed CTaa can be recognized by R*. This induces
the ﬁnal ﬁtting process with R* and results in CTa’s a-he-
lical conformation with helix-terminating C-capping (equi-
librium2 in Fig. 8B).
Further studies are necessary to prove this hypothesis
and to address what conformational changes in the G pro-
tein are needed to make CTa available for R*. Although
many investigations aimed to provide information about
the CTa/R* interface (Acharya, Saad, & Karnik, 1997;
Aris et al., 2001; Cai, Itoh, & Khorana, 2001; Ernst
et al., 2000b; Garcia et al., 1995; Janz & Farrens, 2004;
Martin et al., 1996; Natochin, Muradov, McEntaﬀer, &
Artemyev, 2000; Onrust et al., 1997; Terakita, Yamashita,
Nimbari, Kojima, & Shichida, 2002; Wang, Kim, Ablo-
nczy, Crouch, & Knapp, 2004), it is still unclear where
CTa exactly binds. Likewise, the functional unit of active
rhodopsin is not yet identiﬁed (see e.g. Chabre & le Maire,
2005; Park, Filipek, Wells, & Palczewski, 2004). Our pro-
posed mechanism is compatible with diﬀerent conceivable
scenarios, e.g. binding of Gt to an activated rhodopsin
monomer; interaction between Gt and a rhodopsin dimer
or even higher oligomer; or binding of Gt to an activated
rhodopsin monomer with subsequent receptor dimeriza-
tion or oligomerization (Herrmann et al., 2006). Future
investigations have to address which of these scenarios
properly describes the rhodopsin/Gt interaction.
Furthermore, it remains to be studied howR* allowsCTa
to reach its ﬁnal binding conformation and whether, for
example, proton transfer reactions such as neutralization
of Lys341 are involved in the binding process. All these stud-
ies have to be done with the full length heterotrimer.
Although Gat-derived peptides may give important infor-
mation which can be obtained more readily, they are,
4592 R. Herrmann et al. / Vision Research 46 (2006) 4582–4593however, incomplete mimics of the full length protein for
gaining both structural and kinetic data as shown in this
article.
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Appendix A
A.1. Kinetic analysis of light scattering binding signals
Data analysis of the binding signals of Ga–CTaL
(Fig. 6B) was performed on the basis of the reaction
scheme presented in Fig. 6A as essentially described previ-
ously (Herrmann et al., 2004). The time dependence of the
concentration of each reactant (i.e. the ﬁrst derivative over
time) can be described by the following equations:
d½CTain=dt ¼ k1;on½CTain þ k1;off ½CTaa ðA:1Þ
d½CTaa=dt ¼ k1;on½CTain  k1;off ½CTaa  k2;on½R
 ½CTaa þ k2;off ½R  CTab ðA:2Þ
d½R=dt ¼ k2;on½R½CTaa þ k2;off ½R  CTab ðA:3Þ
d½RCTab=dt ¼ k2;on½R½CTaa  k2;off ½R  CTab ðA:4Þ
The light scattering change DI/I is proportional to the con-
centration of the formed complex R*ÆCTab. Therefore, the
experimental values for DI/I could be ﬁtted according to
dðDI=IÞ=dt ¼ f ðd½R  CTab=dtÞ; ðA:5Þ
using a scaling factor f (for further details see Ref. Heck &
Hofmann (2001)).
Before generation of R*, the initial values for [CTain] and
[CTaa] are determined by equilibrium 1 in Fig. 6A as follows:
½CTain ¼ ½CTatot=ð1þ k1;on=k1;offÞ ðA:6Þ
and ½CTaa ¼ ½CTatot=ð1þ k1;off=k1;onÞ ðA:7Þ
where [CTa]tot depicts the total amount of protein in solu-
tion. The initial conditions were: [R*] = 1 lM; DI/I = 0;
[R*ÆCTab] = 0; [CTa]tot for each binding signal were as
depicted in Fig. 6B. The parameters k1,on, k1,oﬀ, k2,on and
k2,oﬀ were allowed to vary.
The set of three binding signals in Fig. 6B was ﬁtted
simultaneously using the diﬀerential equations and initial
conditions above and a numerical multiple least square ﬁt
procedure (Scientist software; MicroMath Scientiﬁc Soft-
ware, Salt Lake City, UT).
A.2. Kinetic analysis of the rate of 4-TP release during the
reaction of peptides with 4-PDS
The analysis of the time dependency of absorption
changes in Fig. 7B was performed on the basis of thereaction scheme in Fig. 7A. The following diﬀerential equa-
tions were used:
d½CTain=dt ¼ k1;on½CTain þ k1;off ½CTaa
 k2½CTain ðA:8Þ
d½CTaa=dt ¼ k1;on½CTain  k1;off ½CTaa ðA:9Þ
d½4 TP=dt ¼ k2½CTain ðA:10Þ
dðDAbs323Þ=dt ¼ eð4 TPÞ323 nm  ðd½4 TP=dtÞ
D; ðA:11Þ
where 19,000 M1 cm1 was used for e(4-TP)323 nm (Cai
et al., 1997) and D = 1 cm for the optical path length.
Due to the 50-fold excess of 4-PDS, the reaction between
peptide and 4-PDS can be described by the apparent ﬁrst
order rate constant k2.
The initial conditions were: [CTa]tot = 45 lM; [4-
TP] = 0 lM; DAbs323 = 0; the initial values for [CTain]
and [CTaa] are given by Eqs. (A.6) and (A.7), respective-
ly. A ﬁt of the ﬁrst data set obtained for the peptide CTat
yielded the parameters k1,on, k1,oﬀ, and k2. The remaining
data of CTat were ﬁtted with ﬁxed values for k1,on and
k1,oﬀ, whereas k2 was allowed to vary. Next, the data
obtained for the peptide CTaL were ﬁtted with a ﬁxed
value for k2, using the average value obtained for the pep-
tide CTat. The parameters k1,on and k1,oﬀ were free to
vary.
A.3. Alternative evaluation of data in Figs. 2 and 5
Considering depletion of the R* binding partner (MBP-
CTa or G protein), data points representing the signal
amplitudes of the light scattering traces can be ﬁtted as
described in Heck and Hofmann (Heck & Hofmann, 1993):
Amplitude
¼ f ½Rtotþ½PtotþKD
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð½Rtotþ½PtotþKDÞ24½Rtotþ½Ptot
q 
2
ðA:12Þ
where [R*]tot depicts the total concentration of light acti-
vated rhodopsin, [P]tot the total concentration of binding
protein, i.e. MBP-CTa or G protein, KD the dissociation
constant and f a scaling factor.
Using this approach, the following dissociation con-
stants were calculated: 1.3 lM MBP–CTaF (Fig. 2) and
0.21 lMGa–CTai, 0.19 lMGa–CTat, 0.09 lMGa–CTaL
(all Fig. 5).
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